FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)

D. Courvoisier; D. Mongin; M. Hetland; K. Pavelka; C. Turesson; S. A. Bergstra; T. K. Kvien; M. J. Santos; V. Hernandez; F. Iannone; J.-e. Gottenberg; X. Mariette; S. Kubo; Y. Tanaka; D. Choquette; R. Ionescu; A. Finckh

doi:10.1136/annrheumdis-2018-eular.3312

FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)

D. Courvoisier, D. Mongin, M. Hetland, K. Pavelka, C. Turesson, S. A. Bergstra, T. K. Kvien, M. J. Santos, V. Hernandez, F. Iannone, J.-e. Gottenberg, X. Mariette, S. Kubo, Y. Tanaka, D. Choquette, R. Ionescu, A. Finckh

Institut for Klinisk Medicin

Originalsprog	Engelsk
Publikationsdato	2018
Antal sider	2
DOI	https://doi.org/10.1136/annrheumdis-2018-eular.3312
Status	Udgivet - 2018

Adgang til dokumentet

10.1136/annrheumdis-2018-eular.3312

599.2.full.pdfForlagets udgivne version, 330 KB

Citationsformater

Courvoisier, D., Mongin, D., Hetland, M., Pavelka, K., Turesson, C., Bergstra, S. A., Kvien, T. K., Santos, M. J., Hernandez, V., Iannone, F., Gottenberg, J., Mariette, X., Kubo, S., Tanaka, Y., Choquette, D., Ionescu, R., & Finckh, A. (2018). FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY). 599-600. https://doi.org/10.1136/annrheumdis-2018-eular.3312

Courvoisier, D, Mongin, D, Hetland, M, Pavelka, K, Turesson, C, Bergstra, SA, Kvien, TK, Santos, MJ, Hernandez, V, Iannone, F, Gottenberg, J, Mariette, X, Kubo, S, Tanaka, Y, Choquette, D, Ionescu, R & Finckh, A 2018, 'FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)', s. 599-600. https://doi.org/10.1136/annrheumdis-2018-eular.3312

@conference{056c302983354675b2df271cb17dba57,

title = "FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)",

author = "D. Courvoisier and D. Mongin and M. Hetland and K. Pavelka and C. Turesson and Bergstra, {S. A.} and Kvien, {T. K.} and Santos, {M. J.} and V. Hernandez and F. Iannone and J.-e. Gottenberg and X. Mariette and S. Kubo and Y. Tanaka and D. Choquette and R. Ionescu and A. Finckh",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.3312",

language = "English",

pages = "599--600",

}

TY - ABST

T1 - FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY)

AU - Courvoisier, D.

AU - Mongin, D.

AU - Hetland, M.

AU - Pavelka, K.

AU - Turesson, C.

AU - Bergstra, S. A.

AU - Kvien, T. K.

AU - Santos, M. J.

AU - Hernandez, V.

AU - Iannone, F.

AU - Gottenberg, J.-e.

AU - Mariette, X.

AU - Kubo, S.

AU - Tanaka, Y.

AU - Choquette, D.

AU - Ionescu, R.

AU - Finckh, A.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.3312

DO - 10.1136/annrheumdis-2018-eular.3312

M3 - Conference abstract for conference

SP - 599

EP - 600

ER -